A Study On Metabolic Surgery
A study by Wei-Jei Lee, Min-Sheng General Hospital, Taiwan shows more health benefits with metabolic surgery before 40 years.
The patient can lose more weight and higher chances of remission of type 2 diabetes (reversal of type 2 diabetes) when the age is less than 40 years. The study was published in the JAMA.
About Type 2 Diabetes
Insulin resistance and the ability to move sugar (or glucose) into cells is the main cause of type 2 diabetes (T2D).
High insulin levels can affect fat metabolism and can cause an increase in body weight. Fat deposits can block the arteries because of diabetes.
Blood sugar levels will be higher after eating food due to insulin resistance and high sugar levels will damage blood vessels.
Trials Of Higher Altitudes
Dr. Kara Marlatt, a postdoctoral researcher at the LSU's Pennington Biomedical Research Center think that people living at higher altitudes may have a lower risk of diabetes and obesity.
The researchers are using a special tent and machine to simulate the high altitude. The participants are going to sleep for 14 nights inside the tent to check the improvement in the insulin sensitivity.
This study can show a new treatment option to control type 2 diabetes (or high blood sugar levels).
The Risk From Major Cardiovascular Events (MACE)
A study on patients of type 2 diabetes (T2D) shows that a steep decline in the function of kidneys over time is associated with major cardiovascular events (MACE).
Four Ways For The Prevention Of Diabetes
Dr. Candice Hall, a California based doctor who believes that diabetes can be reversed. She gave four-step formula to prevent type 2 diabetes (T2D).
About CVS Pharmacy
CVS Pharmacy becomes an exclusive store for the American Diabetes Association. Both organizations are going to raise awareness and funding for diabetes featuring diabetes, nutrition and health care products.
CVS Pharmacy store is going to display products and information to help people with diabetes disease under "Partner in Healthy Living" initiative.
About MannKind Corporation
MannKind Corporation has collaborated with JDRF. With this collaboration, MannKind Corporation can utilize the scientific and human resources of JDRF in diabetes research and development. The MannKind Corporation is focusing on the needs of people living with type 1 diabetes (T1D).
Partnership Between The American Diabetes Association (ADA) And Watson Health
IBM Watson Health and the American Diabetes Association (ADA) are working together to identify, manage and prevent diabetes.
IBM has research experience in diabetes management. They recently worked on an individualized ranking of risk factors for diabetes. Now the collaboration is going to develop tools which can help organizations in the treatment of diabetes.
The Risk From Heart Disease
A study led by Dr. William White, University of Connecticut School of Medicine, Farmington, has found that a patient of type 2 diabetes suffering from heart disease is more dangerous than previously thought.
An acute coronary syndrome (ACS) to a patient of type 2 diabetes (T2D) may lead to a major cardiac event and the patient needs more attention. Patients hospitalized from congestive heart failure may have 24 to 28 percent higher risk of death within 18 months. Both heart disease and type 2 diabetes (T2D) have obesity as a common risk factor.
The study shows that the function of the heart may be affected due to medications (drugs, tablets, pills or insulin injections) to control blood sugar. The study was published in the journal Diabetes Care.
Cybersecurity For Diabetes Devices
The Diabetes Technology Society (DTS) has released DTSec standard, the guidelines for connected diabetes devices. Some of the diabetes products are.
The DTSec standard contains performance requirements to improve the cybersecurity (IT security). The DTSec standard is based on the ISO/IEC 15408 framework.
Life-critical devices in the network have to comply with the DTSec standard. The lead author of the standard was David Kleidermacher.
The Risk From Underperforming Thyroid
Dr. Minisha Sood, an endocrinologist says there is a link between diabetes and underperforming thyroid.
An eight-year follow-up study by Dr. Layal Chaker on about 8,500 people shows that the risk of diabetes increased by 13 percent due to the underperformance of the thyroid gland. The study was published in a peer-reviewed medical journal.
The Treatment For Diabetic Foot Ulcer With ReGenerCell
The Avita Medical Ltd has started the clinical trial to cure Diabetic Foot Ulcer (DFU) with the ReGenerCell device at Manchester Royal Infirmary, UK.
The first patient for the clinical trial was enrolled in the UK. Avita Medical Ltd is planning to enroll up to 24 patients for the 26-week clinical evaluation.
The ReGenerCell device can enable the production of Regenerative Epithelial Suspension (RES) in 30 minutes. The device uses a small sample of the skin of the patient. The Regenerative Epithelial Suspension can help the natural healthy skin development and healing.
M2D2 is a joint venture between the University of Massachusetts Lowell and Worcester campuses. M2D2 is inviting open competition to identify and to accelerate advances in diabetes research and care in areas such as Devices, Diagnostics, Therapeutics and Technologies.
The submission for the competition is open till July 11, 2016. The two winners will be awarded to up to $150,000 in cash or services.
Benefits Of Quorn, A Meat Substitute From UK
A study on Quorn (a meat substitute in the UK) was published in the British Journal of Nutrition. The study shows that Quorn brand mycoprotein food can improve the functioning of the pancreas, reduce the energy intake in obese people, prevents the development of type 2 diabetes (T2D) Mellitus and obesity.
The study shows that Quorn is a vegetarian and a meat substitute. Mycoprotein in Quorn is high in protein and fiber.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.